Smarter pricing. stronger positioning. greater impact.
TURN INSIGHT INTO COMMERCIAL ADVANTAGE IN MEDTECH.
Conjoint analysis has become the gold standard for understanding customer value, but true commercial success comes from turning that insight into action.
From value-based pricing and revenue modelling to cross-functional alignment, this whitepaper reveals how MedTech leaders can transform preference data into real-world profit.
Why read this whitepaper
Pricing in MedTech is at a critical inflection point.
As procurement becomes value-driven and stakeholders multiply, traditional cost-plus and competitor benchmarking approaches no longer deliver the clarity or confidence needed for commercial success.
This exclusive IDR Medical whitepaper shows how manufacturers can bridge the gap between customer preference and commercial reality, using conjoint analysis not just as research, but as a strategic engine for pricing, growth, and innovation.
Inside, You’ll Learn:
Preference vs. Market Reality
Why conjoint preference share doesn’t equal market share, and how this gap uncovers the commercial barriers shaping purchasing decisions.
Turning Preferences Into Price
How willingness-to-pay and elasticity metrics translate into real, achievable pricing strategies that reflect value, not assumptions.
From Insight to Profit
How to integrate conjoint data with market size, budget cycles, margins, and costs to forecast revenue, profit, and adoption trajectories.
Embedding Value Evidence Across the Business
How conjoint outputs can align marketing, R&D, finance, and leadership around a shared definition of customer value.
Who should read this:
This Whitepaper is designed for:
- MedTech executives responsible for pricing, market access, and commercial strategy
- Product and portfolio leaders seeking evidence-based differentiation
- R&D and innovation teams prioritizing features that drive willingness to pay
- Investors and market analysts evaluating commercial potential in competitive markets
- Commercial, marketing, and finance teams working to align around customer value
Key Takeaway
The MedTech companies that win the next decade will be those that transform customer insights into commercial reality, creating pricing strategies that are evidence-based, value-aligned, and profit-focused.
Conjoint analysis is more than a research method.
It’s a strategic framework for smarter decisions, stronger market position, and accelerated growth.
Download the Whitepaper Now
Unlock the full roadmap for converting conjoint insight into commercial success.